Every week we breakdown a company in a refreshingly simple way.
In this episode, Dan and Albert talk about CSL Limited. CSL is the one of largest global biotech companies in the world. It is listed on the Australian Securities Exchange and operates to deliver science therapies such as plasma-derived immunoglobulins for the treatment of immune deficiencies and neurological conditions, in its CSL Behring division, and influenza vaccines, in its Seqirus division.
In this episode we cover:
CSL's two business divisions, CSL Behring and Seqirus
How blood and plasma donations occur
What plasma-derived therapies CSL Behring have in the pipeline
What COVID-19 means for CSL's vaccine operations
Whether CSL can continue to innovate and stay ahead of the competition
Follow and subscribe to our content.
CSL Plasma Coupon).
All information contained in this podcast is for education and entertainment purposes only. It is not intended as a substitute for professional financial, legal or tax advice. The hosts of Fresh Capital are not financial professionals and are not aware of your personal financial circumstances. Any opinions expressed herein are not recommendations or advice. Please consult a licensed financial professional before you invest.
For more information visit our website at https://freshcapital.show/)
